Brain Tumor Diagnosis And Therapeutics Market Will Reach USD 773.1 Million By 2025:Grand View Research, Inc.
The global brain tumor diagnosis and therapeutics market is
expected to reach USD 773.1 million by 2025, according to a new report by Grand
View Research, Inc. The market is expected to pose lucrative growth over the
forecast period, owing to increasing incidence of various brain cancers,
particularly glioblastoma, coupled with rising geriatric population.
Increasing Public-Private Partnerships (PPPs) in the health
sector, which are modernizing diagnostic imaging and radiology services, are
supporting the expansion of this industry. Emerging technologies like Sodium
Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography
(PET), and Chemical Exchange Saturation Transfer (CEST) are used to detect the
response of brain tumors in multicenter clinical trial settings. In addition,
these technologies are helpful in quantitatively imaging tumor response to
therapies, thereby promoting their use during treatment.
These technologies have the potential to extend MRI beyond
anatomical imaging by providing information on physiology and cellular
metabolism, thereby increasing the efficiency of diagnosis. Hence, the market
is expected to witness productive growth over the forecast period.
Moreover, ongoing research in molecular diagnostics to
understand cell biology at cellular level of malignancy and identification of
gene mutations associated with malignancy is anticipated to significantly
contribute toward the growth of the industry.
On the other hand, high cost of diagnosing brain tumors,
which ranges from USD 450 to 12,200, is likely to hinder the growth of the global
brain tumor diagnosis market.
Browse full research report on Brain Tumor Diagnosis And Therapeutics Market http://www.grandviewresearch.com/industry-analysis/brain-tumor-diagnosis-and-therapeutics-market
Further Key Findings From the Study Suggest:
- CT
scan segment held a lucrative revenue share in 2015 and is also likely to
grow at a significant rate during the forecast period
- Chemotherapy
is anticipated to witness the fastest growth over the forecast period
owing to presence of a large research pipeline by the industry players.
- North
America is expected to dominate the brain tumor diagnosis and therapeutics
market, owing to developed healthcare infrastructure coupled with rising
awareness regarding advanced technologies amongst the population in this
region. In addition, increasing consumer disposable income supported by
healthcare insurance and reimbursement policies in the U.S. is expected to
spur growth.
- Some
of the key players for the brain tumor diagnosis and therapeutics market
are GE Healthcare; Hitachi, Ltd.; Philips Healthcare; Siemens
Healthineers; Toshiba Corporation; Fujifilm Corporation; Shimadzu
Corporation; Carestream Health; Merck & Co.; Astra Zeneca; Bristol
Myer Squibb; Novartis; and Roche Diagnostics.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global brain tumor
diagnosis and therapeutics market on the basis of type, therapeutics, and
region:
Brain Tumor Diagnosis Type Outlook (Revenue, USD
Million, 2014 - 2025)
- MRI
- CT
Scan
- Tissue
Sampling
- PET-CT
Scan
- Cerebral
Arteriogram
- Lumbar
Puncture
- Molecular
Testing
- EEG
Brain Tumor Therapeutics Outlook (Revenue, USD Million,
2014 - 2025)
- Surgery
- Radiation
Therapy
- Chemotherapy
- Immunotherapy
- Targeted
Therapy
Brain Tumor Diagnosis and Therapeutics Regional Outlook
(Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa (MEA)
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-brain-tumor-diagnosis-therapeutics-market
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information: www.grandviewresearch.com
Comments
Post a Comment